Glyconics wins UK government grant for feasibility study on low-cost diabetic screening in developing countries
Innovative diagnostics company, Glyconics, has won an £85,000 Phase 1 grant from the Global Challenges Research Fund (GCRF) to explore the feasibility of implementing a novel low-cost point-of-care diagnostic platform for diabetic screening in developing countries.
Glyconics® awarded internationally recognised quality certification for diagnostic medical devices
Innovative diagnostics company, Glyconics® has been awarded an internationally recognised quality certification for the design and development of its medical devices product range.
Glyconics© appoints new Non-Executive Director at 'exciting time for the business'
Innovative diagnostics company, Glyconics© appoints Dr Joanne Phoenix as a non-executive board director.
World’s first hand-held infrared devices for COPD and other conditions to be produced
A hand-held device that would give early warning of ‘acute events’- and so avoid the hospitalisation of thousands of patients with chronic obstructive pulmonary disease (COPD) - is to go into production ahead of clinical trials. This follows an agreement between medical diagnostics company Glyconics and Spectrolytic, a leading developer of infrared (IR) spectrometers.